Evidence map›Paper›PMID 36386935›Full record

ArticleFrontiers in nutrition2022

Antidiabetic activity of

Namani Satyanarayana, Suresh V Chinni, Ramachawolran Gobinath, Paripelli Sunitha, Akula Uma Sankar, Bala Sundaram Muthuvenkatachalam

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Development of Anti-Inflammatory Drug fromJournal of pharmacy & bioallied sciences · 2024
    Article
  7. Study on Antidiabetic Potential ofJournal of pharmacy & bioallied sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Namani SatyanarayanaDepartment of Anatomy, Saint James School of Medicine, Saint Vincent, Saint Vincent and the Grenadines.
Suresh V ChinniDepartment of Biochemistry, Faculty of Medicine, Bioscience, and Nursing, MAHSA University, Jenjarom, Selangor, Malaysia.
Ramachawolran GobinathDepartment of Foundation, RCSI and UCD Malaysia Campus, Georgetown, Pulau Pinang, Malaysia.
Paripelli SunithaDepartment of Physiology, Saint James School of Medicine, Saint Vincent, Saint Vincent and the Grenadines.
Akula Uma SankarFaculty of Medicine, Biochemistry Unit, AIMST University, Bedong, Kedah, Malaysia.
Bala Sundaram MuthuvenkatachalamFaculty of Medicine, Biochemistry Unit, AIMST University, Bedong, Kedah, Malaysia.
AIMST University · MYMahsa University · MYRCSI & UCD Malaysia Campus · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Materials and methods: Acute toxicity study was done according to OECD-423 guidelines. Diabetes was induced by intraperitoneal (i.p.) injection of streptozotocin (55 mg/kg) in male Sprague-Dawley rats. Experimental diabetic rats were divided into six different groups; normal, diabetic control, and glibenclamide at 6 mg/kg body weight, and the other three groups of animals were treated with oral administration of ethanolic extract of Results: Acute toxicity studies showed LD Conclusion: Ethanolic extract of

Indexed as

antidiabetic activitygene expressionhepatoprotective activitylipid profileSolanum torvumstreptozotocin

Identifiers

PMID36386935
PMCPMC9650639
OpenAlexW4307927238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.